In contrast, by measuring PD-1, PD-L1, CD4 and CD8 by IHC on sequential tumor slices, it has been possible to identify some immune checkpoint inhibitor-responsive melanom patients (Tumeh et al., 2014). The gene discussed is CD4; the disease is neoplasm.